{"id":268312,"date":"2026-09-24T15:21:15","date_gmt":"2026-09-24T09:51:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=268312"},"modified":"2026-09-24T15:21:15","modified_gmt":"2026-09-24T09:51:15","slug":"oral-solid-dosage-stock-rises-87-percent-in-6-months","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/oral-solid-dosage-stock-rises-87-percent-in-6-months\/","title":{"rendered":"This Oral Solid Dosage Stock Rises 87% in 6 Months: What Is Fueling the Rally?"},"content":{"rendered":"

CMP approximately Rs 1,290 (24 Sep 2026). 6-month return approximately 87%. 52W range Rs 622 to Rs 1,353.50. Market cap Rs 7,436 Cr. Q1 FY27 PAT Rs 44.13 Cr, up 42% YoY.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Innova Captab, a pharmaceutical contract manufacturer of tablets, capsules and other oral formulations, is the oral solid dosage stock that climbed approximately 87% in six months, from about Rs 691 on 24 March 2026 to around Rs 1,290 on 24 September 2026. The rally followed a sharp Q1 FY27 earnings jump, a ramp-up at its new Jammu plant and a regulatory tailwind from tighter pharma manufacturing norms. At a trailing PE near 48 against an industry PE of about 38, valuation has already priced in a good part of the growth story.<\/p>\n<\/div>\n

An oral solid dosage stock from the domestic pharma contract manufacturing space has turned into one of the sharpest recoveries on the small-cap board. This oral solid dosage stock gained approximately 87% in six months, moving from a depressed base in March 2026 to a fresh high in September 2026, among a screen of NSE small-cap stocks ranked by 6-month return, dated 24 September 2026.<\/p>\n

The company behind this move is Innova Captab Ltd<\/a> (NSE: INNOVACAP)<\/strong>, a pharma CDMO that manufactures tablets, capsules, ointments and dry syrups for more than 350 domestic and export pharma brands out of its Baddi and Jammu facilities. Most of its output carries the labels of the pharma companies that commission it, which makes it one of the larger listed names focused on third-party formulation manufacturing in India.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n